SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is currently experiencing significant price volatility, driven by a combination of broader market anxiety regarding the geopolitical situation in Iran and high-frequency trading activity around the upcoming SpaceX IPO narrative. The community remains deeply polarized, with bulls pointing to the proximity of the BlueBird launch and strategic institutional partnerships as catalysts for a potential reversal, while bears are focusing on technical breakdowns, production delays, and negative price momentum to justify their short positions.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund (USO) is experiencing high volatility as market participants weigh conflicting signals regarding a potential ceasefire against President Trump's recent vows to intensify military actions in Iran. The community remains deeply divided, with many traders aggressively betting on further supply disruptions and sustained high energy prices, while others warn of potential market manipulation and a possible correction if the geopolitical situation de-escalates.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The S&P 500 is experiencing heightened volatility and selling pressure as market participants react to geopolitical instability and shifting rhetoric surrounding the Iran conflict, fueling concerns over energy prices and broader economic growth. Community sentiment is deeply polarized, with many investors debating whether this price action represents a capitulation, a bear trap, or a structural correction while closely monitoring the potential for further military escalation.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as traders speculate on a semiconductor sector reversal, fueled by ongoing geopolitical tensions in the Middle East and concerns over supply chain disruptions. Community discussion remains heavily polarized between those betting on a major market correction and those warning about the inherent decay and risks associated with holding this leveraged ETF long-term.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing intense market volatility and community debate as investors react to the President's upcoming address regarding the ongoing Middle East conflict. The discussion is sharply polarized, with traders expressing concerns over potential market-moving policy shifts and geopolitical instability, while many in the community are actively debating the broader economic impacts of the administration's current military strategy.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense market interest following reports that Amazon is in advanced talks to acquire the satellite telecommunications firm, sparking a potential bidding war against competitors like SpaceX. The community is actively debating the strategic value of Globalstars unique spectrum and its existing partnership with Apple, which adds significant complexity to any potential buyout.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing high volatility as investors weigh the stock's role in the AI memory supercycle against ongoing geopolitical tensions in the Middle East. While some community members are betting on a rapid recovery fueled by strong demand for DRAM and HBM, others remain cautious, debating whether recent price action is a sustainable bounce or a temporary bear trap driven by conflicting reports on regional instability.

Invesco QQQ Trust Series 1 - Units of beneficial interest

QQQ is experiencing intense volatility as traders react to President Trump's recent address, which signaled an escalation in military operations against Iran rather than the ceasefire market participants had hoped for. The community is sharply divided, with bulls trapped in 'fake-out' rallies while bears argue that persistent geopolitical uncertainty and the potential for a prolonged ground conflict will keep energy prices elevated and pressure tech valuations.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing extreme volatility driven by shifting geopolitical headlines surrounding the ongoing conflict in the Middle East and concerns over semiconductor supply chains. The community remains deeply divided, with some traders actively scaling into long positions to capitalize on oversold conditions, while skeptics warn of potential bull traps and argue that the broader structural trend remains bearish.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending following the announcement of a new contract from a NATO ally for its Black Widow drones, sparking intense debate among community members regarding the company's long-term contract visibility versus ongoing volatility and dilution concerns. Investors are actively discussing the stock's role in the broader defense sector, with many focused on how recent strategic partnerships and government procurement trends might impact future growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>PMGC Holdings (ELAB) is a holding company that acquires and runs businesses in manufacturing, biotech, and investments.</li><li>On Wednesday, the company announced&nbsp;the sale of $4.5 million of discounted stock to Streeterville Capital.</li><li>Stocktwits sentiment for ELAB remained ‘extremely bullish.’</li></ul>Shares of PMGC Holdings, Inc. (ELAB) staged a stunning run – soaring roughly 760% over the past three days – after one of its subsidiaries secured a long-term defense contract and the company’s annual report showed a 43% jump in assets.But the momentum appears to be faltering. ELAB shares&nbsp;crashed 52% overnight ahead of Thursday, following the company's announcement of a new share placement.<h2 class="st-heading-2">ELAB Dilution Concerns</h2>PMGC Holdings is raising another $4.55 million by issuing discounted stock to Streeterville Capital under an ongoing equity line, while registering those shares for resale, according to an exchange&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/Archives/edgar/data/1840563/000121390026038645/0001213900-26-038645-index.htm">filing</a> late Wednesday.&nbsp;The move raised concerns about further dilution of the micro-cap stock. In September 2025, the company signed a $20 million equity line of credit facility (ELOC) and has tapped it multiple times since. With the latest placement, the credit line is fully utilized. “The proceeds are intended for general corporate purposes and potential acquisitions of operating companies,” the filing said.&nbsp;Streeterville is a Utah-based investment firm linked to John Fife, who in 2020 was charged by the Securities and Exchange Commission with operating as a “toxic lender” for years.&nbsp;Fife and his companies would purchase convertible notes from small, struggling companies, convert them into shares at substantial discounts, and sell the resulting stock without being registered as dealers — violating federal securities laws,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/enforcement-litigation/litigation-releases/lr-24886">according to the SEC</a>.<h2 class="st-heading-2">Retail’s View On ELAB</h2>On Stocktwits, traders appeared confused about the ELAB stock slide, given that the company was exercising a previously approved facility. Still, retail sentiment remained ‘extremely bullish,’ unchanged since the start of the week, although many expected significant volatility in the near term.$ELAB this is absolutely insane,”&nbsp;<a href="https://stocktwits.com/Costco_plays/message/649231502">remarked</a> a user. “A lot of panic sellers. But honestly, for me, my average was $7.X . Not that upset about this. It's setting up to be a very volatile stock that can squeeze heavy come tomorrow and Monday morning will be fun.”Another&nbsp;<a href="https://stocktwits.com/Costco_plays/message/649230144">wrote</a>: “Sooo like let me get this straight... It runs 133% (on Wednesday) and then drops 50%+ ? Do I smell manipulation? At these prices I'm sure people are going to buy this like crazy. Tomorrow we'll see a pop to $9 by morning bell.”<h2 class="st-heading-2">Recent Catalysts For ELAB</h2>PMGC Holdings is a diversified public holding company focused on acquiring and scaling cash-flowing businesses, primarily in U.S.-based manufacturing and industrial sectors, as well as in biotech and investment activities.&nbsp;Earlier this week, its engineering components unit AGA Precision Systems announced a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/elab-stock-extends-rally-after-unit-signs-long-term-defense-deal/cZEPyYORIVl">long-term agreement</a> with Turbo-Jet Products Co. to supply mission-critical components for commercial and defense programs. Consequently, ELAB shares doubled on Monday.Last week, SVM Machining, another of PMGC’s units, secured ITAR registration from the U.S. Department of State, which allows it to work on controlled defense projects and positions it to enter U.S. military supply chains and regulated aerospace programs.&nbsp;Despite this week's rally,&nbsp;<a href="https://stocktwits.com/symbol/ELAB">ELAB shares</a> are still 60.6% lower year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ncno-stock-posts-best-day-in-7-months-after-strong-q4-analysts-still-see-over-50-upside/cZ7xQHeRIFN">NCNO Stock Posts Best Day In 7 Months After Strong Q4: Analysts Still See Over 50% Upside</a>

A trader checking stock market charts. ELAB shares dropped 52% overnight ahead of Thursday. (Picture source: Getty Images)

Why ELAB Stock Is Crashing Over 50% Overnight After 8x Surge This Week

Shares of PMGC Holdings, Inc. (ELAB) staged a stunning run – soaring roughly 760% over the past three days but ELAB shares crashed 52% overnight ahead of Thursday.

Equity

Retail investors on Stocktwits expect the stock to remain volatile.


<ul class="summary-bullets"><li>The deals, spread across more than 20 enterprise customers, are expected to generate approximately $7.5 million in revenue for the remainder of 2026.</li><li>The company currently has more than 30 active deployments spanning AI-native startups and established enterprises.</li></ul>&nbsp;Shares of Axe Compute Inc. (AGPU) closed 120% higher on Wednesday and edged up 19% after hours after the company said that it has signed deals worth about $12 million in total in the last 30 days, setting the stage for an estimated $835,000 in monthly recurring income as the company enters the second quarter.The deals, spread across more than 20 enterprise customers, are expected to generate approximately $7.5 million in revenue for the remainder of 2026 based on the current monthly run rate. The company currently has more than 30 active deployments spanning AI-native startups and established enterprises, with GPU hardware ranging from NVIDIA RTX 5090s to H100, H200 and B200 architectures.“This is not a marketing milestone — it is executed agreements from enterprises with production AI workloads,” said Chris Miglino, chief executive officer of Axe Compute. “Every agreement signed strengthens the foundation of the business. This is the beginning of our income from our GPU business and we are excited for this growth.”<h2 class="st-heading-2">About Axe Compute</h2>Axe Compute structures its enterprise contracts with monthly payments made in advance against reserved capacity, a model designed to minimize receivables risk and deliver predictable cash flow. The company says the payment terms reflect customer confidence in its ability to deliver reliable infrastructure quickly.The company positions itself as the enterprise GPU marketplace, giving AI innovators and enterprises access to any GPU architecture in any of 200+ global locations, deployed in as little as 24-48 hours. It was called Predictive Oncology until December and then renamed itself as part of its transformation to AI compute infrastructure. &nbsp;Earlier this week, the company reported full year total revenue of $125,284, derived entirely from the company’s drug discovery services legacy segment, and net loss from continuing operations of $232.9 million.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around AGPU stock rose from ‘bullish’ to ‘extremely bullish’ over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.A Stocktwits user expressed optimism over the pace at which the company landed GPU agreements.<stembedurl>https://www.stocktwits.com/Shake_Daddy/message/649223855</stembedurl>Another said that the pivot into AI compute is “working very well.”<stembedurl>https://www.stocktwits.com/Cpt_Sergio/message/649223370</stembedurl><a href="https://stocktwits.com/symbol/AGPU">AGPU stock</a> &nbsp;has lost 84% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/alto-neuroscience-schizophrenia-study-fails/cZ7HygQRIFi">ANRO Stock On Investors’ Radar After Failed Schizophrenia Study Results</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Did AGPU Stock Rise 120% Today?

The company signed deals worth $12 million, setting the stage for income from its new compute segment.

<ul class="summary-bullets"><li>Alto will now focus on its other programs including ALTO-207 in development for treatment -resistant depression.</li><li>The company said that it also intends to explore partnering opportunities for a modified-release oral formulation of ALTO-101 that it has developed.</li></ul>Shares of Alto Neuroscience, Inc. (ANRO) fell as much as 10% after hours on Wednesday after the company said that its experimental drug for the treatment of schizophrenia failed to achieve statistical significance on key goals in a mid-stage study.The company was studying ALTO-101 for the treatment of cognitive impairment associated with schizophrenia. However, no statistically significant changes were detected on primary electroencephalography or cognitive endpoints as compared to placebo, the company said.<h2 class="st-heading-2">Plans Ahead</h2>As a result, the company does not intend to independently advance ALTO-101 in CIAS anymore, it said, while adding that it would now focus on its other programs including ALTO-207 in development for treatment -resistant depression. Alto is looking to initiate a mid-stage trial for &nbsp;ALTO-207 in the first half of 2026. &nbsp;The company said that it now intends to explore partnering opportunities for a modified-release oral formulation of ALTO-101 that it has developed. The formulation has demonstrated an improved pharmacokinetic and tolerability profile when compared to the immediate-release formulation, Alto said, while adding that it believes the formulation may offer potential benefits across several therapeutic areas.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around ANRO &nbsp;stayed within the ‘bearish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.A Stocktwits user noted the company’s balance sheet, terming it an “easy short.”<stembedurl>https://www.stocktwits.com/Shortski/message/649224122</stembedurl>The company said earlier this month that it had cash, cash equivalents, and restricted cash of approximately $177 million as of the end of 2025, expected to support its planned operations into 2028.Another user termed the selloff an “overreaction.”<stembedurl>https://www.stocktwits.com/RazorbackAJ/message/649224026</stembedurl> <a href="https://stocktwits.com/symbol/ANRO">ANRO stock</a> has gained 32% this year.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-agpu-stock-rise-today/cZ7HyVtRIF0">Why Did AGPU Stock Rise 120% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Alto Neuroscience logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

ANRO Stock Falls After Hours On Failed Schizophrenia Study Results

Alto Neuroscience does not intend to independently advance ALTO-101 in CIAS anymore, it said. 

<ul class="summary-bullets"><li>RenX stated that it completed its first deliveries in the premium compost market in 2025 and closed the year with $1.08 million in finished goods inventory.</li><li>The company also stated that it expects the Microtec UTM 1200 Turbo Mill precision milling system to arrive at the Myakka City facility in April 2026.</li><li>RenX added that it expects installation and commissioning to be completed within 2026, with commercial production targeted to begin in the second half of the year.</li></ul>RenX Enterprises Corp. (RENX) shares rallied more than 34% in Wednesday’s pre-market trade after the company beat its post-acquisition revenue guidance.RenX announced its fiscal year 2025 results, reporting $8.2 million in post-acquisition revenue following the June 2025 acquisition of RGUS. Its management guided for post-acquisition revenue of $7 million at the time.RenX said it retired $11.9 million in legacy debt, transitioning from a real estate holding company to a compost producer during the year.“The substrate industry is facing a supply chain problem that plays directly to our model. We enter 2026 with the platform in place and the market moving in our direction,” said RenX CEO David Villarreal.<h2 class="st-heading-2">First Deliveries In Compost Market</h2>RenX stated that it completed its first deliveries in the premium compost market in 2025 and closed the year with $1.08 million in finished goods inventory.The company also stated that it expects the Microtec UTM 1200 Turbo Mill precision milling system to arrive at the Myakka City facility in April 2026. RenX added that it expects installation and commissioning to be completed within 2026, with commercial production targeted to begin in the second half of the year.RenX stated that the Microtec precision milling system processes material already on-site and converts it into premium substrate products that command significantly higher per-ton prices than the current bulk compost output.Noting that the incremental economics of this system are “highly favorable,” RenX stated that it expects the system to drive consolidated gross margins toward 60% and above as it ramps, subject to production volume and market conditions.For fiscal 2025, RenX posted $15.9 million in loss and a blended gross margin of 29.1%.&nbsp;<h2 class="st-heading-2">RenX Completes Reverse Stock Split</h2>Last week, the company announced the completion of a 1-for-20 reverse stock split to regain compliance with Nasdaq’s minimum bid price requirements.Following this, the number of outstanding shares of the company’s common stock has been reduced to 2.5 million from 50 million, RenX said.In February 2026, RenX announced a private placement of $6 million primarily to meet its working capital requirements.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/RENX">RenX Enterprises</a> trended in the ‘neutral’ territory at the time of writing.One user highlighted that the RENX stock more than tripled in February, while noting that it remains to be seen if the company can maintain a higher market capitalization this time.<stembedurl>https://stocktwits.com/erb71/message/649153004</stembedurl>Another user stated that they are watching for a potential stock squeeze.<stembedurl>https://stocktwits.com/DPaul5151/message/649154121</stembedurl><a href="https://stocktwits.com/symbol/RENX">RENX stock</a> is down 53% year-to-date and 93% over the past 12 months. The Vanguard Extended Market Index Fund ETF (VXF) is up 19% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nke-stock-tumbles-q4-outlook-china-weakness-nike-stock-downgrade-pt-cuts/cZ7HkFpRInM">Nike’s China Bet Is Under Pressure And Wall Street Is Losing Confidence – Analysts Warn Return To Growth Could Take 4 Quarters</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of stock chart rising

RENX Stock Soars As RenX Enterprises Beats Post-Acquisition Revenue Guidance, Transitions From Real Estate To Compost Producer

RenX management guided for a post-acquisition revenue of $7 million, while the company reported $8.2 million in sales since closing the acquisition of RGUS through the end of 2025.

<ul class="summary-bullets"><li>New Era Energy added that the TCDC project is expected to be structured through a newly formed Delaware limited liability company.</li><li>The project’s financing will be led by an unnamed institutional investor, with debt accounting for about 80% of the funding, it said.</li><li>New Era Energy stated that its equity position in the venture is expected to generate distributions from operating cash flow after commercial operations of the first phase commence.</li></ul>New Era Energy &amp; Digital Inc. (NUAI) shares gained nearly 6% in Wednesday’s opening trade after the company announced a partnership for its flagship Texas data center facility.New Era Energy stated that it has entered into a non-binding letter of intent (LOI) to form a joint venture with Stream Data Centers for the development and financing of the company’s Texas Critical Data Centers (TCDC) facility in West Texas.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/NUAI">New Era Energy</a> trended in the ‘bearish’ territory at the time of writing.<h2 class="st-heading-2">Stream To Develop And Manage NUAI’s Facility</h2>New Era Energy stated that Stream will develop and manage the company’s data center facility, while leveraging the former’s local relationships.It added that the TCDC project is expected to be structured through a newly formed Delaware limited liability company. The project’s financing will be led by an unnamed institutional investor, with debt accounting for about 80% of the funding.The company added that its equity position in the venture is expected to generate distributions from operating cash flow after commercial operations of the first phase commence, providing a near-term path to recurring revenue.“This LOI represents an important step in advancing TCDC toward delivery, and we remain focused on progressing toward a definitive agreement with Stream,” said New Era Energy CEO E. Will Gray II.He added that the company expects to invest in the project alongside its partner amid a growing need for purpose-built, power-ready data center infrastructure.<h2 class="st-heading-2">TCDC Campus Spread Across 438 Acres</h2>New Era Energy’s TCDC campus is located in the Permian Basin of West Texas. The campus is spread across 438 acres owned by the company, with an additional 54-acre corridor that is currently pending approval.The TCDC campus is designed for a total capacity of over a gigawatt, with the expansion planned across three phases. The first phase will kick off with 200 megawatt capacity, while the second phase will add another 450 MW capacity. New Era Energy states that it will utilize utility-sourced power and on-site gas-fired energy in these two phases.The third phase is expected to take the total capacity to over a gigawatt. The company has projected that power delivery will be achieved by the end of 2027.In January 2026, New Era Energy&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-nuai-stock-falling-today/cmyR4nVR4gX">announced</a> plans to raise up to $350 million to fund acquisitions, pay or refinance debt, meet capital expenditures, and other working capital requirements.<h2 class="st-heading-2">How Did Retail Traders React?</h2>One user stated that the partnership announced on Wednesday removes one of the biggest question marks for the company going forward.<stembedurl>https://stocktwits.com/roiger/message/649150963</stembedurl>Another user stated that this is big news for New Era Energy, adding that the company is “completely derisked now.”<stembedurl>https://stocktwits.com/YoloAlfred/message/649150643</stembedurl><a href="https://stocktwits.com/symbol/NUAI">NUAI stock</a> is up 39 % year-to-date and 256% over the past 12 months. The Vanguard Total Stock Market Index Fund ETF (VTI) is up 17% over the past 12 months, while the Vanguard Extended Market Index Fund ETF (VXF) is up 20%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nke-stock-tumbles-q4-outlook-china-weakness-nike-stock-downgrade-pt-cuts/cZ7HkFpRInM">Nike’s China Bet Is Under Pressure And Wall Street Is Losing Confidence – Analysts Warn Return To Growth Could Take 4 Quarters</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Computer racks in Data Center (Representative image courtesy of Arctic-Images via Getty Images)

Why Is NUAI Stock Rising Today? A Texas Data Center Deal Could Be Key

New Era Energy stated that it has entered into a non-binding letter of intent to form a joint venture with Stream Data Centers to develop and finance the facility.

<ul class="summary-bullets"><li>Korsana stated that it has secured $380 million in commitments from private investors to support the merger transaction.</li><li>The company added that its cash and cash equivalents balance at the closing of the transaction, including the funds from the private placement, is anticipated to fund the company’s operations into 2029.</li><li>Korsana expects the financing round to close immediately prior to the proposed merger.</li></ul>Cyclerion Therapeutics Inc. (CYCN) shares more than tripled in Wednesday’s opening trade, rallying by more than 274% after the company announced a deal with Korsana Biosciences Inc.Cyclerion stated that it has entered into a definitive merger agreement for an all-stock transaction. The merged entity will operate under the name Korsana Biosciences Inc., and trade on the Nasdaq under the ticker symbol ‘KRSA’.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/CYCN">Cyclerion Therapeutics</a> trended in the ‘neutral’ territory at the time of writing.<h2 class="st-heading-2">Korsana Secures $380M In Commitments To Support Merger</h2>Korsana stated that it has secured $380 million in commitments from private investors to support the merger transaction. The investment is led by Fairmount and Venrock Healthcare Capital Partners, with participation from General Atlantic, TCGX, Forbion, and Wellington Management, among others.The company expects the financing round to close immediately prior to the proposed merger.Korsana stated that its cash and cash equivalents balance at the closing of the transaction, including the funds from the private placement, is anticipated to fund the company’s operations into 2029, providing it with runway through key clinical milestones.“With our seasoned team and support from leading biotechnology investors, Korsana is well-positioned to advance a pipeline of innovative, next generation therapies,” said Korsana CEO Jonathan Violin.<h2 class="st-heading-2">What Does Korsana Do?</h2>Korsana is a Waltham, Massachusetts-based company that is engaged in the development of therapeutics to treat neurodegenerative diseases.Its lead program is KRSA-028, a next-generation shuttle antibody targeting amyloid beta for the treatment of Alzheimer’s disease, discovered in partnership with Paragon Therapeutics.KRSA-028 is designed to enhance amyloid plaque clearance, lower amyloid-related imaging abnormalities (ARIA) and hematologic risks, and improve convenience through low-volume subcutaneous delivery.<a href="https://stocktwits.com/symbol/CYCN">CYCN stock</a> is up 357% year-to-date and 128% over the past 12 months. The Vanguard Extended Market Index Fund ETF (VXF) is up 19% over the past 12 months, while the Fidelity Nasdaq Composite Index ETF (ONEQ) is up 25%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ipm-bcg-hubc-stocks-top-premarket-gainers-april-1-2026/cZ7H1jsRInn">IPM, BCG, HUBC Among Stocks Soaring Before The Bell — Top Pre-Market Gainers Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

CYCN Stock Is Soaring 274% Today — What Is Fueling The Rally?

Cyclerion stated that it has entered into a definitive merger agreement with Korsana Therapeutics in an all-stock transaction.

<ul class="summary-bullets"><li>Earlier this month, Classover announced a reverse stock split in a bid to regain compliance with Nasdaq’s listing rules and meet the $1 minimum bid price requirement to ensure its securities remain listed on the stock exchange.</li><li>The company announced a 1-for-50 reverse stock split of its Class A common stock and Class B common stock, which went into effect on March 9, 2026.</li><li>Classover stated that it was notified by the Nasdaq that its stock had stayed above the $1 level for the previous 12 consecutive business days.</li></ul>Classover Holdings Inc. (KIDZ) shares soared nearly 61% in Tuesday’s pre-market trade after the company announced that it has regained compliance with the Nasdaq’s minimum bid price requirement.Classover stated that regaining compliance with Nasdaq’s listing rules will eliminate uncertainties regarding the trading of its securities.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/KIDZ">Classover Holdings</a> trended in the ‘neutral’ territory at the time of writing.<h2 class="st-heading-2">Classover Announced A Reverse Stock Split Earlier</h2>Earlier this month, Classover announced a reverse stock split in a bid to regain compliance with Nasdaq’s listing rules and achieve the $1 minimum bid price requirement to ensure its securities continued to be listed on the stock exchange.The company announced a 1-for-50 reverse stock split of its Class A common stock and Class B common stock, which went into effect on March 9, 2026.As a result of the reverse split, the number of outstanding shares of Class A common stock as of March 4, 2026 were reduced from 6.5 million to 130,700, and the number of outstanding shares of Class B common stock as of March 4, 2026, were reduced from 54.9 million to 1,097,731.<h2 class="st-heading-2">What Are Nasdaq’s Minimum Bid Price Requirements?</h2>The Nasdaq’s minimum bid price requirements for continued listing mandate that a company’s shares should be at or above $1 per share.If a stock falls below this level for 30 consecutive business days, the company is served a deficiency notice. Following this, the recipient is required to maintain a minimum bid price of $1 for at least 10 consecutive business days to regain compliance.Classover stated that it was notified by the Nasdaq that its stock had stayed above the $1 level for the previous 12 consecutive business days.<a href="https://stocktwits.com/symbol/KIDZ">KIDZ stock</a> is down 77% year-to-date and 99% over the past 12 months. The Vanguard Extended Market Index Fund ETF (VXF) is up 15% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/jeremy-siegel-us-stocks-fall-further-strait-hormuz-dow-fall-3800-points-iran-war/cZEPMsjRIVJ">Jeremy Siegel Warns US Stocks May Slide Further If Hormuz Crisis Drags On – Dow Is Already Down Nearly 3,800 Points Since Iran War Began</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

KIDZ Stock Rallies 61% Pre-Market Today — What Is Driving The Surge?

Classover stated that regaining compliance with Nasdaq’s listing rules will eliminate uncertainties with respect to the trading of its securities.

<ul class="summary-bullets"><li>Bullfrog AI CEO Vin Singh stated that the agreement the company struck is a validation of its capabilities.</li><li>He remains confident that Bullfrog’s relationship with the pharmaceutical company will expand to other areas of its research and development portfolio.</li><li>Bullfrog uses AI with its bfLEAP, bfPREP, and bfARENAS platforms to provide developers with a path to discover and characterize drug targets for diseases like major depressive disorder.</li></ul>Bullfrog AI Holdings Inc. (BFRG) shares gained more than 152% in Monday’s opening trade after the company announced a deal with a major global pharmaceutical giant.Bullfrog AI stated that its agreement requires the company to use its bfLEAP program to identify and prioritize novel drug targets in major depressive disorder (MDD). The company stated that this is aimed at accelerating its drug discovery and clinical development programs.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/BFRG">Bullfrog AI</a> trended in the ‘extremely bullish’ territory with message volumes at ‘high’ levels at the time of writing.<h2 class="st-heading-2">Agreement Is A Validation Of Bullfrog’s Capabilities, Says CEO</h2>Bullfrog AI CEO Vin Singh stated that the agreement the company struck is a validation of its capabilities.“Our bfLEAP, bfPREP, and bfARENAS integrated platform leverages causal network inference to provide drug developers a clearer path forward in the discovery and characterization of drug targets for a complex disease like MDD,” Singh added. He remains confident that Bullfrog’s relationship with the pharmaceutical company will expand to other areas of its research and development portfolio.MDD is a mental health condition that is characterized by a loss of interest in activities or persistent and intense sadness. It is also called clinical or unipolar depression.The company stated that data from Stellar Market Research shows that the MDD market was valued at more than $8 billion in 2025 and is expected to reach $11 billion by 2032.<h2 class="st-heading-2">What Does Bullfrog AI Do?</h2>Bullfrog AI is a Gaithersburg, Maryland-based company that uses artificial intelligence and machine learning to advance drug discovery and development.The company stated that it uses AI in combination with its bfLEAP platform to analyze complex biological data, aiming to accelerate drug development and reduce clinical trial failure rates.<a href="https://stocktwits.com/symbol/BFRG">BFRG stock</a> is up 31% year-to-date, but down 32% over the past 12 months. The Vanguard Total Stock Market Index Fund ETF (VTI) is up 15% over the past 12 months, while the Vanguard Extended Market Index Fund ETF (VXF) is up 16%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-vrdn-stock-falling-today/cZERVHrRIZD">VRDN Stock Plummeted 41% Pre-Market Today — What Did Its Phase 3 Active Thyroid Eye Disease Trial Reveal?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

BFRG Stock More Than Doubled Today — What Is Fueling The Surge?

Bullfrog AI announced an agreement with a major global pharmaceutical company to accelerate its drug discovery and clinical development programs.

<ul class="summary-bullets"><li>The company stated that it expects to fund the share repurchases through its existing cash reserves and cash flow.</li><li>Roma Green Finance was founded in 2018 and offers core sustainability program development and ESG reporting services to clients.</li><li>The company states that it helps corporate customers enhance their ESG performance.</li></ul>Roma Green Finance (ROMA) shares soared more than 10% in Monday’s pre-market trade&nbsp;before paring some of the gains as the company announced a $100 million share repurchase program.Roma Green Finance stated that the program authorized by its board of directors will remain in effect until Dec. 31, 2028.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/ROMA">Roma Green Finance</a> trended in the ‘bullish’ territory with message volumes at ‘high’ levels at the time of writing.The company stated that it expects to fund the share repurchases through its existing cash reserves and cash flow.<h2 class="st-heading-2">What Does Roma Green Finance Do?</h2>Roma Green Finance is a Cayman Islands-incorporated holding company. It conducts its operations through a specialist in the environmental, social, and governance (ESG), as well as the sustainability and climate change-related sectors.Roma Green Finance was founded in 2018 and offers core sustainability program development and ESG reporting services to clients. The company claims to help corporate customers enhance their ESG performance.The company filed a prospectus with the U.S. Securities and Exchange Commission (SEC) in February 2026 to offer, in one or more offerings, up to $1 billion in aggregate of its Class A ordinary shares and rights. The company noted that its operating subsidiaries conduct their business in Hong Kong and Singapore.Roma Green Finance stated that it intends to use the proceeds of its issue for general corporate purposes, including funding its projects, supporting business growth, meeting expenses for research and development activities, or for its working capital or capital expenditure requirements.The company also stated that it intends to retain any future earnings to finance its operations rather than distribute cash dividends.<h2 class="st-heading-2">How Did Retail Traders React?</h2>ROMA stock was among the top trending tickers on Stocktwits at the time of writing.<a href="https://stocktwits.com/symbol/ROMA">ROMA stock</a> is up 273% year-to-date and 729% over the past 12 months. The Vanguard Extended Market Index Fund ETF (VXF) is up 14% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/top-premarket-stocks-making-the-biggest-moves-today-march-30-2026/cZERZMmRIZ">Top Pre-Market Gainers Today — ELAB, ITRM, LTRN Among Stocks Soaring Before The Bell</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

ROMA Stock Shot Up 10% Today – Everything To Know About Its Gigantic Share Repurchase Program

Roma Green Finance stated that the program authorized by its board of directors will remain in effect until Dec. 31, 2028.

Shares of Cue Biopharma (CUE) fell 8% in extended trading hours on Friday after the company announced that its top leader Usman Azam has stepped down as president and CEO, effective March 26.Azam also resigned from his role as a director of the company. Azam was appointed into the role in late-September, replacing former CEO Daniel Passeri, and served merely six months in the role. &nbsp;<h2 class="st-heading-2">New CEO</h2>Lucinda Warden has been appointed interim president and CEO, the company said. Warden served as Cue Biopharma’s chief financial and business officer since Feb. 2026, and previously as Cue Biopharma’s chief business officer from Sept. 2024 until Feb. 2026.Prior to working with Cue, Warden was employed with Johnson &amp; Johnson and Janssen Biologics.<h2 class="st-heading-2">Cue Pipeline</h2>Boston, Massachusetts-headquartered Cue Biopharma is now looking to progress CUE-401 into clinical trials by the second half of this year. The investigational drug is the company’s lead asset for the treatment of autoimmune and inflammatory diseases. In preclinical studies, CUE-401 was well tolerated with no adverse events observed.In November, Cue also entered into a collaboration and license agreement with ImmunoScape, Pte. Ltd, a biotechnology company, to advance a novel in vivo approach to cell therapy for the treatment of solid tumors.Under the agreement, ImmunoScape will develop a novel Seed-and-Boost immunotherapy that combines Cue Biopharma’s clinically-validated Immuno-STAT T-cell engagers, with ImmunoScape’s proprietary T cell receptors.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around CUE stock stayed within the ‘bearish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.<a href="https://stocktwits.com/symbol/CUE">CUE stock</a> has fallen 76% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/alt-stock-nearly-halved-in-past-year-but-wall-street-sees-almost-500-percent-upside/cZ3HgAcRImK">ALT Stock Has Nearly Halved In The Past Year, So Why Does Wall Street See Almost 500% Upside?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Cue Biopharma logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

CUE Stock Slips As CEO Leaves After Just Six Months In Role

Usman Azam was appointed into the role in late-September, replacing former CEO Daniel Passeri.  

Vanguard Index Funds - Vanguard Extended Market Index ETF

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

VXF
Vanguard Extended Market ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest VXF News

VXFVanguard Extended Market ETF